跳转至内容
Merck
Search Within

231-072-3

应用筛选条件
关键词:'231-072-3'
显示 1-1 共 1 条结果 关于 "231-072-3" 范围 论文
Danique Giesen et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 26(15), 3999-4009 (2020-01-19)
Probody therapeutic CX-072 is a protease-activatable antibody that is cross-reactive with murine and human programmed death-ligand 1 (PD-L1). CX-072 can be activated in vivo by proteases present in the tumor microenvironment, thereby potentially reducing peripheral, anti-PD-L1-mediated toxicities. To study its
1/1